Supplementary Table S1 from A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies

Autor: Pamela N. Munster, Mark M. Moasser, Jennifer Grabowsky, Scott Thomas, Delaire Fattah, Jose Garcia, Romain Pacaud, Susan Calabrese, Edwin A. Alvarez, Emily K. Bergsland, Mallika S. Dhawan, Rahul R. Aggarwal, Erica S. Tsang
Rok vydání: 2023
DOI: 10.1158/2767-9764.22545363.v1
Popis: A) Rationale for study drug dose interruption or reduction; B) Rationale for cisplatin dose interruption or reduction; C) Cisplatin dose intensity, stratified by dose level
Databáze: OpenAIRE
načítá se...